Wells Fargo & Company Cumberland Pharmaceuticals Inc Call Options Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CPIX
# of Institutions
21Shares Held
1.83MCall Options Held
36.4KPut Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny507KShares$2.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA374KShares$1.84 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX273KShares$1.34 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA188KShares$925,7660.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX184KShares$906,0420.01% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $72.1M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...